BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30221603)

  • 1. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
    Mitoma H; Manto M; Hampe CS
    Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune-Mediated Cerebellar Ataxias].
    Mitoma H
    Brain Nerve; 2023 Jun; 75(6):737-747. PubMed ID: 37287357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune-Mediated Cerebellar Ataxias].
    Mitoma H
    Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.
    Manto M; Mitoma H
    J Integr Neurosci; 2024 Apr; 23(4):79. PubMed ID: 38682229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
    Mitoma H; Manto M; Hadjivassiliou M
    J Mov Disord; 2021 Jan; 14(1):10-28. PubMed ID: 33423437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
    Hadjivassiliou M; Manto M; Mitoma H
    Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.
    Manto M; Mitoma H
    Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated ataxias: Guide to clinicians.
    Meira AT; de Moraes MPM; Ferreira MG; Franklin GL; Rezende Filho FM; Teive HAG; Barsottini OGP; Pedroso JL
    Parkinsonism Relat Disord; 2023 Dec; 117():105861. PubMed ID: 37748994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated cerebellar ataxias: from bench to bedside.
    Mitoma H; Manto M; Hampe CS
    Cerebellum Ataxias; 2017; 4():16. PubMed ID: 28944066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebellar Ataxia and Autoantibodies].
    Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
    Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated ataxias.
    Joubert B; Rostásy K; Honnorat J
    Handb Clin Neurol; 2018; 155():313-332. PubMed ID: 29891069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.
    Desai J; Mitchell WG
    J Child Neurol; 2012 Nov; 27(11):1482-8. PubMed ID: 22805251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated acquired ataxias.
    Hadjivassiliou M
    Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-Mediated Cerebellar Ataxia Associated With Neuronal Surface Antibodies.
    Jia Y; Li M; Li D; Zhang M; Wang H; Jiao L; Huang Z; Ye J; Liu A; Wang Y
    Front Immunol; 2022; 13():813926. PubMed ID: 35250990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
    Mitoma H; Adhikari K; Aeschlimann D; Chattopadhyay P; Hadjivassiliou M; Hampe CS; Honnorat J; Joubert B; Kakei S; Lee J; Manto M; Matsunaga A; Mizusawa H; Nanri K; Shanmugarajah P; Yoneda M; Yuki N
    Cerebellum; 2016 Apr; 15(2):213-32. PubMed ID: 25823827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical presentation of immune mediated cerebellar ataxia].
    Honnorat J; Trouillas P
    Rev Neurol (Paris); 2003 Jan; 159(1):11-22. PubMed ID: 12618649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Era of Cerebellar Therapy.
    Mitoma H; Manto M
    Curr Neuropharmacol; 2019; 17(1):3-6. PubMed ID: 30582473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for treatment of immune-mediated cerebellar ataxias.
    Mitoma H; Hadjivassiliou M; Honnorat J
    Cerebellum Ataxias; 2015; 2():14. PubMed ID: 26561527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
    Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
    Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.